Clinical Trial

Leading Mid-Atlantic Insurance Provider Publishes New Coverage Policy for Nerivio® REN Wearable, Granting 3.4 million People with Access to Drug-Free Migraine Care

New policy recognizes the Nerivio REN wearable as medically necessary for both acute and preventive treatment of migraine in patients…

2 months ago

Waterdrop Inc. Announces Third Quarter 2025 Unaudited Financial Results, Net profit rises 60.1% year-on-year

BEIJING, Dec. 3, 2025 /PRNewswire/ -- On December 3, 2025, Waterdrop Inc. (NYSE: WDH), a leading technology platform dedicated to insurance…

2 months ago

Hoggan Scientific, LLC Receives U.S. Department of Veterans Affairs Federal Supply Schedule (FSS) Contract

Hoggan Scientific, LLC Awarded FSS Contract Provides Direct Access To Its Medical Dynamometers for Veterans Administration Hospitals and Other Federal…

2 months ago

Key Narmafotinib Patent Granted in the U.S.

Highlights The Company has received a Certificate of Grant from the US Patent and Trademark Office for a key patent…

2 months ago

BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product

First Hydration Formula Powered by VINIA's Blood Flow Technology Enters the $13 Billion U.S. Electrolyte MarketVancouver, British Columbia and Rehovot,…

2 months ago

Waterdrop Inc. Announces Third Quarter 2025 Unaudited Financial Results

BEIJING, Dec. 3, 2025 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated…

2 months ago

President Trump Fixing DEA Marijuana Policy: Defies Logic, Law, and Science, Says MMJ International Holdings

MMJ International Holdings Exposes the Impossible Federal Catch-22 Blocking FDA Regulated Cannabis Medicine. "This is an equation with no solution.…

2 months ago

Avetra Launches as a Next-Generation, Site-Centric CRO Transforming Clinical Trial Operations

RALEIGH, N.C., Dec. 2, 2025 /PRNewswire/ -- Avetra, a next-generation Contract Research Organization (CRO), today announced its official launch, introducing…

2 months ago

DiagnosTear Announces Clinical Study with AlyaTec to Advance Analytical Validation and FDA Submission Pathway of TeaRx(TM) Red Eye Diagnostic Test

Vancouver, British Columbia--(Newsfile Corp. - December 2, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"),…

2 months ago

Avisi Technologies Announces First Patient Implanted with VisiPlate® Glaucoma Treatment Device in the SAPPHIRE Trial

The first VisiPlate surgery in the US for the SAPPHIRE Trial was performed by Dr. Snyder of Sacramento Eye Consultants,…

2 months ago